NCT04699305 Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers
| NCT ID | NCT04699305 |
| Status | Recruiting |
| Phase | — |
| Sponsor | RedDress Ltd. |
| Condition | Cutaneous Wounds |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2019-02-14 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2019-02-14 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Multicenter observational study to explore the efficacy of ActiGraft in the treatment of exuding cutaneous wounds in real-life usage.
Eligibility Criteria
Inclusion Criteria: * Subject is ≥18 years of age * Subject has an exuding cutaneous wound * Subject agrees to the use of his health data, including photos of his wound in analysis and publications * Subject/LAR must be able to read and understand English and/or Spanish Exclusion Criteria: * Subject/LAR is unable to read and understand English or Spanish.
Contact & Investigator
Sharon Sirota
STUDY DIRECTOR
RedDress Ltd.
Frequently Asked Questions
Who can join the NCT04699305 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cutaneous Wounds. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04699305 currently recruiting?
Yes, NCT04699305 is actively recruiting participants. Contact the research team at sharon@reddress.co.il for enrollment information.
Where is the NCT04699305 trial being conducted?
This trial is being conducted at Las Vegas, United States.
Who is sponsoring the NCT04699305 clinical trial?
NCT04699305 is sponsored by RedDress Ltd.. The principal investigator is Sharon Sirota at RedDress Ltd.. The trial plans to enroll 500 participants.